Skip to main content
SpringerLink
Log in

Antibiotic Therapy

  • Chapter
Pediatric Inflammatory Bowel Disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5S–11S.

    PubMed  CAS  Google Scholar 

  2. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn disease in the neoterminal ileum. Lancet 1991;338:771–74.

    Article  PubMed  CAS  Google Scholar 

  3. Perencevich M and Burakoff R. Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2006;12:651–664.

    Article  PubMed  Google Scholar 

  4. Ursing B, Alm, T, Barany F, et al. Comparative study of metronidazole and sulfasalazine for active Crohn disease: the cooperative Crohn disease study in Sweden. Gastroenterology 1982;83:550–562.

    PubMed  CAS  Google Scholar 

  5. Rutgeerts P, Hile M, Geboes K, et al. Controlled trial of metronidazole for prevention of Crohn recurrence after ileal resection. Gastroenterology 1995;108:1617–21.

    Article  PubMed  CAS  Google Scholar 

  6. Hildebrand H, Berg NO, Hoevels J, et al. Treatment of Crohn disease with metronidazole in childhood and adolescence. Gastroenterol Clin Biol 1980;4:19–25.

    PubMed  CAS  Google Scholar 

  7. Ursing B and Kamme C. Metronidazole for Crohn disease. Lancet 1975;1:775–777.

    Article  Google Scholar 

  8. Sutherland L, Singleton J, Sessions J, et al. Double-blind placebo controlled trial of metronidazole in Crohn disease. Gut 1991;32:1071–1075.

    Article  PubMed  CAS  Google Scholar 

  9. Colombel JF, Lemann M, Cassagnou M, et al. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn disease. Am J Gastroenterol 1999;94:674–678.

    Article  PubMed  CAS  Google Scholar 

  10. Arnold GL, Beaves MR, Pryjdun VO, et al. Preliminary study of ciprofloxacin in active Crohn disease. Inflamm Bowel Dis 2002;8:10–15.

    Article  PubMed  Google Scholar 

  11. Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn disease. Can J Gastroenterol 1998;12:53–56.

    PubMed  CAS  Google Scholar 

  12. Prantera C, Zannoni F, Scribano ML, et al. An antibiotic regimen for the treatment of active Crohn disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996;91:328–332.

    PubMed  CAS  Google Scholar 

  13. Prantera C, Berto E, Scribano ML, et al. Use of antibiotics in the treatment of active Crohn disease: experience with metronidazole and ciprofloxacin. Ital J Gastroenterol Hepatol 1998;30:602–606.

    PubMed  CAS  Google Scholar 

  14. Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis and treatment of perianal fistulas in Crohn disease. Ann Intern Med 2001;135:906–18.

    PubMed  CAS  Google Scholar 

  15. Allan R and Cooke WT. Evaluation of metronidazole in the management of Crohn disease. Gut 1977;18:A422.

    Google Scholar 

  16. Bernstein LH, Frank MS, Brandt LJ, et al. Healing of perianal Crohn disease with metronidazole. Gastroenterology 1980;79:357–365.

    PubMed  CAS  Google Scholar 

  17. Brandt LJ, Bernstein LH, Boley SJ, et al. Metronidazole therapy for perianal Crohn disease: a follow-up study. Gastroenterology 1982;83:383–387.

    PubMed  CAS  Google Scholar 

  18. Dejaco C, Harrer M, Waldhoer T, et al. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn disease. Aliment Pharmacol Ther 2003;18:1113–1120.

    Article  PubMed  CAS  Google Scholar 

  19. West RL, Van Der Woude CJ, Hansen BE, et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn disease with infliximab: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2004;20:1329–1336.

    Article  PubMed  CAS  Google Scholar 

  20. Baldassano RN, Han PD, Jeshion WC, et al. Pediatric Crohn disease: Risk factors for postoperative recurrence. Am J Gastroenterol 2001;96:2169–2176.

    Article  PubMed  CAS  Google Scholar 

  21. Penner RM, Madsen KL, Fedorak RN. Postoperative Crohn disease. Inflamm Bowel Dis 2005;11:765–777.

    Article  PubMed  Google Scholar 

  22. D’Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn disease caused by infusion of Intestinal contents in excluded ileum. Gastroenterology 1998;114:262–267.

    Article  PubMed  CAS  Google Scholar 

  23. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn disease recurrence after ileal resection. Gastroenterology 1995;108:1617–1621.

    Article  PubMed  CAS  Google Scholar 

  24. Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005;128:856–861.

    Article  PubMed  CAS  Google Scholar 

  25. Dickinson RJ, O’Connor HJ, Pinder I, et al. Double-blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 1985;26:1380–84.

    Article  PubMed  CAS  Google Scholar 

  26. Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as adjunct to corticosteroids in severe ulcerative colitis. Gut 1986;27:1210–12.

    Article  PubMed  CAS  Google Scholar 

  27. Mantzaris GJ, Archavlis E, Christoforidis P, Kourtessas D, Amberiadis P, Florakis N, Petraki K, Spiliadi C, Triantafyllou G. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am J Gastroenterol 1997;92:454–56.

    PubMed  CAS  Google Scholar 

  28. Mantzaris GJ, Archavlis E, Christoforidis P, Kourtessas D, Amberiadis P, Florakis N, Petraki K, Spiliadi C, Triantafyllou G. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am J Gastroenterol 1997;92:454–56.

    PubMed  CAS  Google Scholar 

  29. Turunen UM, Farkkila MA, Hakala K, Seppala K, Sivonen A, Ogren M, Vuoristo M, Valtonen VV, Miettinen TA. Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-bind, placebo-controlled study. Gastroenterology 1998;115:1072–78.

    Article  PubMed  CAS  Google Scholar 

  30. Gilat T, Suissa A, Leichtman G, et al. A comparative study of metronidazole and sulfasalazine in active, not severe, ulcerative colitis. J Clin Gastroenterol 1987;9:415–417.

    Article  PubMed  CAS  Google Scholar 

  31. Burke DA, Axon AT, Clayden SA, et al. The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990;4:123–129.

    Article  PubMed  CAS  Google Scholar 

  32. Lobo AJ, Burke DA, Sobala GM, et al. Oral tobramycin in ulcerative colitis: effect on maintenance of remission. Aliment Pharmacol Ther 1993;7:155–158.

    Article  PubMed  CAS  Google Scholar 

  33. Mantzaris GJ, Hatzis A, Kontogiannis P, et al. Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Am J Gastroenterol 1994;89:43–46.

    PubMed  CAS  Google Scholar 

  34. Ohkusa T, Nomura T, Terai T, et al. Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up. Scand J Gastroenterol 2005;40:1334–1342.

    Article  PubMed  CAS  Google Scholar 

  35. Shafran I and Johnson LK. An open-label evaluation of rifaximin in the treatment of active Crohn disease. Cur Med Res Opin 2005;21:1165–69.

    Article  CAS  Google Scholar 

  36. Kornbluth A, Hunt M, George J, et al. Efficacy and safety of rifaximin in the treatment of mild-moderate Crohn disease: results of an open-label pilot study. Gastroenterology 2005;128:A579.

    Google Scholar 

  37. Campieri M, Rizzello F, Venturi A, Poggioli G, Ugolini F, Helwig U, Amadini C, Romboli E, Gionchetti P. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn disease: A randomized controlled study versus mesalazine. Gastroenterology 2000;118(suppl 1):A781.

    Article  Google Scholar 

  38. Gionchetti P, Rizzello F, Ferrieri A, Venturi A, Brignola C, Ferretti M, Peruzzo S, Miglioli M, Campieri M. Rifaximin in patients with moderate to severe ulcerative colitis refractory to steroid-treatment: A double-blind, placebo-controlled trial. Dig Dis Sci 1999;44:1220–21.

    Article  PubMed  CAS  Google Scholar 

  39. Lukas M, Konecny M, Zboril V. Rifaximin in patients with mild to moderate activity of ulcerative colitis: An open label study. Gastroenterology 2002;122:A434.

    Google Scholar 

  40. Guslandi M, Giolla P, Testoni PA. Corticosteroid-sparing effect of Rifaximin, a nonabsorbable oral antibiotic, in active ulcerative colitis: preliminary clinical experience. Current Therapeutic Research 2004;65(3):292–96.

    Article  CAS  Google Scholar 

  41. Kornbluth, A, Hunt M, George J, Rochester J, Fried-Boxt E, Legnani P. An open label pilot trial of Rifaximin in the treatment of patients with refractory pouchitis. Gastroenterology 2006;130:A-658.

    Google Scholar 

  42. Gionchetti P, Rizzello F, Venturi A, Ugolini F, Rosi M, Brigidi P, Johansson R, Ferrieri A, Poggioli G, Campieri M. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999;13:713–18.

    Article  PubMed  CAS  Google Scholar 

  43. Duffy LF, Daum F, Fisher SE, et al. Peripheral neuropathy in Crohn disease patients treated with metronidazole. Gastroenterology 1985;88:681–84.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Gastroenterology, Sinai Hospital of Baltimore, 2411 W Belvedere Avenue, Suite 407,. Baltimore, MD, 21215-5217

    Douglas Jacobstein

Authors
  1. Douglas Jacobstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Howard Kader
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Attending Physician, Division of GI Hepatology and Nutrition, Director Endoscopy Suite, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Petar Mamula M.D. (Assistant Professor of Pediatrics) (Assistant Professor of Pediatrics)

  2. Attending Physician, Children’s Center for Digestive Health, Greenville Hospital System University Medical Center, University of South Carolina School of Medicine, Greenville, South Carolina, USA

    Jonathan E. Markowitz M.D., M.S.C.E. (Associate Professor of Clinical Pediatrics) (Associate Professor of Clinical Pediatrics)

  3. Attending Physician and Director, Inflammatory Bowel Disease Center Division of GI, Hepatology and Nutrition. The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Robert N. Baldassano M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Jacobstein, D., Kader, H. (2008). Antibiotic Therapy. In: Mamula, P., Markowitz, J.E., Baldassano, R.N. (eds) Pediatric Inflammatory Bowel Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-73481-1_25

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-73481-1_25

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-73480-4

  • Online ISBN: 978-0-387-73481-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation